Lifecore Biomedical Inc
NASDAQ:LFCR

Watchlist Manager
Lifecore Biomedical Inc Logo
Lifecore Biomedical Inc
NASDAQ:LFCR
Watchlist
Price: 6.47 USD 1.73% Market Closed
Market Cap: 239.6m USD

Wall Street
Price Targets

LFCR Price Targets Summary
Lifecore Biomedical Inc

Wall Street analysts forecast LFCR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LFCR is 8.67 USD with a low forecast of 7.07 USD and a high forecast of 10.5 USD.

Lowest
Price Target
7.07 USD
9% Upside
Average
Price Target
8.67 USD
34% Upside
Highest
Price Target
10.5 USD
62% Upside
Lifecore Biomedical Inc Competitors:
Price Targets
42W
China Star Food Group Ltd
112% Upside
BIKAJI
Bikaji Foods International Ltd
19% Upside
002726
Shandong Longda Meishi Co Ltd
21% Upside
PATANJALI
Patanjali Foods Ltd
23% Upside

Revenue
Forecast

Revenue Estimate
Lifecore Biomedical Inc

For the last 8 years the compound annual growth rate for Lifecore Biomedical Inc's revenue is -15%. The projected CAGR for the next 3 years is 7%.

-15%
Past Growth
7%
Estimated Growth
Estimates Accuracy
-13%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Lifecore Biomedical Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Lifecore Biomedical Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
66%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is LFCR's stock price target?
Price Target
8.67 USD

According to Wall Street analysts, the average 1-year price target for LFCR is 8.67 USD with a low forecast of 7.07 USD and a high forecast of 10.5 USD.

What is Lifecore Biomedical Inc's Revenue forecast?
Projected CAGR
7%

For the last 8 years the compound annual growth rate for Lifecore Biomedical Inc's revenue is -15%. The projected CAGR for the next 3 years is 7%.

Back to Top